SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D - General statement of acquisition of beneficial ownership:
SEC Accession No. 0001140361-23-049040
Filing Date
2023-10-20
Accepted
2023-10-20 16:29:11
Documents
2
Group Members
LEEN KAWASPROPEL BIO PARTNERS LLCRICHARD KAYNERICHARD KAYNE & SUZANNE KAYNE LIVING TRUST DTD 01/14/1999

Document Format Files

Seq Description Document Type Size
1 SC 13D ef20012872_sc13d.htm SC 13D 224228
2 EXHIBIT 99.1 ef20012872_ex99-1.htm EX-99.1 12028
  Complete submission text file 0001140361-23-049040.txt   237964
Mailing Address 2155 PARK BOULEVARD PALO ALTO CA 94306
Business Address 2155 PARK BOULEVARD PALO ALTO CA 94306 650-279-9845
Eiger BioPharmaceuticals, Inc. (Subject) CIK: 0001305253 (see all company filings)

IRS No.: 361004130 | Fiscal Year End: 1231
Type: SC 13D | Act: 34 | File No.: 005-87931 | Film No.: 231337418
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 1800 AVENUE OF THE STARS LOS ANGELES CA 90067-4201
Business Address 1800 AVENUE OF THE STARS LOS ANGELES CA 90067-4201 908-507-9629
Propel Bio Management, LLC (Filed by) CIK: 0001969764 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D